AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 Jan 2004 07:00 AM
RNS
Nexium NSAID
28 Jan 2004 09:00 AM
RNS
Notice of Results
23 Jan 2004 05:48 PM
RNS
Holding(s) in Company
22 Jan 2004 02:30 PM
RNS
Holding in Company
13 Jan 2004 07:00 AM
RNS
Seroquel
23 Dec 2003 03:15 PM
RNS
Exanta
23 Dec 2003 01:15 PM
RNS
Exanta
19 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
18 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
15 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
12 Dec 2003 09:30 AM
RNS
Prilosec Appeal Result
12 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
10 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
09 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
08 Dec 2003 07:01 AM
RNS
Exanta
08 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
04 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
02 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
01 Dec 2003 07:00 AM
RNS
Purchase of Own Securities
28 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
27 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
26 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
24 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
21 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
20 Nov 2003 04:00 PM
RNS
Director Shareholding
19 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
18 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
17 Nov 2003 08:30 AM
RNS
Symbicort Turbuhaler
14 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
13 Nov 2003 04:23 PM
RNS
Director Shareholding
13 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
11 Nov 2003 02:00 PM
RNS
Exanta
07 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
05 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
04 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
31 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
30 Oct 2003 01:00 PM
RNS
Seroquel Approvable Letter
30 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
29 Oct 2003 04:53 PM
RNS
Director Shareholding
29 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
27 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
23 Oct 2003 11:00 AM
RNS
3rd Quarter Results -Part 2/2
23 Oct 2003 11:00 AM
RNS
3rd Quarter Results -Part 1/2
23 Oct 2003 09:33 AM
RNS
Correction to Notice
22 Oct 2003 09:00 AM
RNS
Notice of 3rd Quarter Results
16 Oct 2003 01:03 PM
RNS
Collaboration with Abgenix
13 Oct 2003 08:30 AM
RNS
Seroquel
02 Oct 2003 01:00 PM
RNS
Annual Business Review
01 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
30 Sep 2003 07:00 AM
RNS
Purchase of Own Securities

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings